Novo Nordisk Shares Face Geopolitical Headwinds from US Tariff Threat
19.01.2026 - 14:49:04 | boerse-global.de
Novo Nordisk investors are navigating a volatile mix of robust commercial performance and emerging political risk. While recent prescription data for a key new product exceeded expectations, a new trade dispute initiated by the United States against Denmark now casts a shadow over future margins and supply chain stability for the pharmaceutical giant.
The market sentiment shifted sharply between Friday and Monday. The week ended on a high note following the release of IQVIA data showing a powerful debut for Novo Nordisk’s oral Wegovy tablet in the crucial US market. In the first four days of its launch, approximately 3,071 prescriptions were filled in US pharmacies. This significantly outpaced Read more...
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Die trading-house Börsenakademie bringt dich in exklusiven Live-Webinaren näher an erfolgreiche Trading-Entscheidungen. 100% kostenlos. 100% Expertenwissen. Erhalte klare Marktanalysen, konkrete Setups und direkt anwendbare Strategien von erfahrenen Profis. Jetzt kostenlos anmelden und live dabei sein.
Kostenlos. Teilnahme. Sichern.
Kostenlos. Teilnahme. Sichern.
DK0062498333 | NOVO | boerse | 68500425 |
